Risk analysis for measles reintroduction after global certification of eradication

Journal of Infectious Diseases

Volumn 204, Issue SUPPL. 1, 2011, Pages

  Sanders, Raymond ^a   Dabbagh, Alya ^b   Featherstone, David ^b  

^a Independent Department   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE;

ARTICLE; BIOLOGICAL WARFARE; DRUG USE; EPIDEMIC; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; INFECTION RISK; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; NONHUMAN; PERSISTENT VIRUS INFECTION; POPULATION SIZE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RISK ASSESSMENT; VIRAL PHENOMENA AND FUNCTIONS; VIRUS REINTRODUCTION; VIRUS REPLICATION; VIRUS TRANSMISSION; WILD TYPE; ANIMAL; DISEASE CARRIER; GENETIC VARIABILITY; GENETICS; GENOTYPE; HEALTH; HEALTH SURVEY; IMMUNOLOGY; PRIMATE; RISK FACTOR; VIROLOGY;

ANIMALS; BIOTERRORISM; DISEASE RESERVOIRS; GENETIC VARIATION; GENOTYPE; HUMANS; MEASLES; MEASLES VACCINE; MEASLES VIRUS; POPULATION SURVEILLANCE; PRIMATES; RISK ASSESSMENT; RISK FACTORS; WORLD HEALTH;

EID: 79960875716     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir133     Document Type: Article

References (50)

1. Keeling MJ, Grenfell BT. Disease extinction and community size: modeling the persistence of measles. Science 1997; 275:65-7.
2. Szusz EK, Garrison LP, Bauch CT. A review of data needed to parameterize a dynamic model of measles in developing countries. BMC Res Notes 2010; 3:75.
3. Helfand RF, Kim DK, Gary HEJ, et al. Nonclassic measles infections in an immune population exposed to measles during a college bus trip. J Med Virol 1998; 56:337-41.
4. Lievano FA, Papania MJ, Helfand RF, et al. Lack of evidence of measles virus shedding in people with inapparent measles virus infections. J Infect Dis 2004; 189(Suppl 1):165-70.
5. Sonoda S, Nakayama T. Detection of measles virus genome in lymphocytes from asymptomatic healthy children. J Med Virol 2001; 65:381-7.
6. Smith FR, Curran AS, Raciti KA, Black FL. Reported measles in persons immunologically primed by prior vaccination. J Pediatr 1982; 101:391-3.
7. World Health Organization. Global distribution of measles and rubella genotypes - update. Wkly Epidemiol Rec 2006; 81:474-9.
8. Rota PA, Featherstone DA, Bellini WJ. Molecular epidemiology of measles virus. Curr Top Microbiol Immunol 2009; 330:129-50.
9. Rota JS, Wang ZD, Rota PA, Bellini WJ. Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains. Virus res 1994; 31:317-30.
10. Rota PA, Khan AS, Durigon E, Yuran T, Villamarzo YS, Bellini WJ. Detection of measles virus RNA in urine Specimens from vaccine recipients. J Clin Microbiol 1995; 33:2485-8.
11. Ward B, Boulianne N, Ratnam S, Guiot MC, Couilard M, De Serres G. Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination. J Infect Dis 1995; 172:1591-5.
12. Cohen JI. Vaccine-associated cases due to immunization with live virus vaccines. In: Knobler S, Lederberg J, Pray LA, ed: Considerations for Viral Disease Eradication: Lessons learned and Future strategies. Washington, DC: National Academy Press, 2002: 90-7.
13. Kobune F, Funatu M, Takahashi H, et al. Characterization of measles viruses isolated after measles vaccination. Vaccine 1995; 13:370-2.
14. Barrero PR, Zandomeni RO, Mistchenko AS. Measles virus circulation in Argentina: 1991-1999. brief report. Arch Virol 2001; 146:815-23.
15. Outlaw MC, Pringle CR. Sequence variation within an outbreak of measles virus in the Coventry area during spring/summer 1993. Virus Res 1995; 39:3-11.
16. Kreis S, Vardas E, Whistler T. Sequence analysis of the nucleocapsid gene of measles virus isolates from South Africa identifies a new genotype. J Gen Virol 1997; 78:1581-7.
17. Santibanez S, Heider A, Gerike E, Agafonov A, Schreier E. Genotyping of measles virus isolates from central Europe and Russia. J Med Virol 1999; 58:313-20.
18. Rota JS, Rota PA, Redd SB, Redd SC, Pattamadilok S, Bellini WJ. Genetic analysis of measles viruses isolated in the United States, 1995-1996. J Infect Dis 1998; 177:204-8.
19. Zhang Y, Zhu Z, Rota PA, et al. Molecular epidemiology of measles viruses in China, 1995-2003. Virol J 2007; 4:14.
20. Ramsay ME, Jin L, White J, Litton P, Cohen B, Brown D. The elimination of indigenous measles transmission in England and Wales. J Infect Dis 2003; 187(Suppl 1):S198-207.
21. Truong AT, Kreis S, Ammerlaan W, et al. Genotypic and antigenic characterization of hemagglutinin proteins of African measles virus isolates. Virus Res 1999; 62:89-95.
22. Mosquera MM, Ory F, Echevarría JE. Measles virus genotype circulation in Spain after implementation of the national measles elimination plan 2001-2003. J Med Virol 2005; 75:137-46.
23. Cheng WY, Lee L, Rota PA, Yang DC. Molecular evolution of measles viruses circulated in Taiwan 1992-2008. Virol J 2009; 6:219.
24. Bellini WJ, Rota PA. Genetic diversity of wild-type measles viruses: implications for global measles elimination programs. Emerg Infect Dis 1998; 4:29-35.
25. Forthal DN, Aarnaes S, Blanding J, de la Maza L, Tilles JG. Degree and length of viremia in adults with measles. J Infect Dis 1992; 166:421-4.
26. Dossetor J, Whittle HC, Geenwood BM. Persistent measles infection in malnourished children. Br Med J 1977; 1:1633-5.
27. Budka H, Urbanits S, Liberski PP, Eichinger S, Popow-Kraupp T. Subacute measles virus encephalitis: a new and fatal opportunistic infection in a patient with AIDS. Neurology 1996; 46:586-7.
28. Nakata Y, Nakayama T, Ide Y, Kizu R, Koinuma G, Bamba M. Measles virus genome detected up to four months in a case of congenital measles. Acta Paediatr 2002; 91:1263-5.
29. Permar S, Moss WJ, Ryon JJ, et al. Prolonged measles virus shedding in human immunodeficiency virus-infected children, detected by reverse transcriptase-polymerase chain reaction. J Infect Dis 2001; 183:532-8.
30. Riddell MA, Moss WJ, Hauer D, Monze M, Griffin DE. Slow clearance of measles virus RNA after acute infection. J Clin Virol 2007; 39:312-7.
31. Pan CH, Valsamakis A, Colella T, et al. Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles. Proc Natl Acad Sci U S A 2005; 102:11581-8.
32. Campbell H, Andrews N, Brown KE, Miller E. Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol 2007; 36:1334-48.
33. Paula-Barbosa MM, Cruz C. Nerve cell fusion in a case of subacute sclerosing panencephalitis. Ann Neurol 1981; 9:400-3.
34. Bitnun A, Shannon P, Durward A, et al. Measles inclusion-body encephalitis caused by the vaccine strain of measles virus. Clin Infect Dis 1999; 29:855-61.
35. Young VA, Rall GF. Making it to the synapse: measles virus spread in and among neurons. Curr Top Microbiol Immunol 2009; 330:3-30.
36. Mustafa MM, Weitman SD, Winick NJ, Bellini WJ, Timmons CF, Siegel JD. Subacute measles encephalitis in the young immuno-compromised host: report of 2 cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature. Clin Infect Dis 1993; 16:654-60.
37. Moss WJ, Fisher C, Scott S, et al. HIV type 1 infection is a risk factor for mortality in hospitalized Zambian children with measles. Clin Infect Dis 2008; 46:523-7.
38. Frenkel LM, Nielsen K, Garakian A, Cherry JD. A search for persistent measles, mumps, and rubella vaccine virus in children with human immunodeficiency virus type 1 infection. Arch Pediatr Adolesc Med 1994; 148:57-60.
39. El Mubarak H, Yüksel S, van Amerongen G, et al. Infection of cynomolgus macaques (Macaca fascicularis) and rhesus macaques (Macaca mulatta) with different wild-type measles viruses. J Gen Virol 2007; 88:2028-34.
40. Jones-Engel L, Engel GA, Schillaci MA, et al. Considering human-primate transmission of measles virus through the prism of risk analysis. Am J Primatol 2006; 68:868-79.
41. de Swart RL. Measles studies in the macaque model. Curr Top Microbiol Immunol 2009; 330:55-72.
42. MacArthur JA, Mann PG, Oreffo V, Scott GB. Measles in monkeys: an epidemiological study. J Hyg 1979; 83:207-12.
43. Jones-Engel L, Engel GA, Schillaci MA, Babo R, Froehlich J. Detection of antibodies to selected human pathogens among wild and pet macaques (Macaca tonkeana) in Sulawesi, Indonesia. Am J Primatol 2001; 54:171-8.
44. Grist NR, Emslie JA. Infections in British clinical laboratories, 1988-1989. J Clin Pathol 1991; 44:667-9.
45. Walker D, Campbell D. A survey of infections in United Kingdom laboratories, 1994-1995. J Clin Pathol 1999; 52:415-8.
46. Pike RM. Laboratory-associated infections: incidence, fatalities, causes, and prevention. Annu Rev Microbiol 1979; 33:41-66.
47. Vesley D, Hartmann HM. Laboratory-acquired infections and injuries in clinical laboratories: a 1986 survey. Am J Public Health 1988; 78:1213-5.
48. Kimman TG, Smit E, Klein MR. Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures. Clin Microbiol Rev 2008; 21:403-25.
49. Musser SJ, Underwood GE, Weed SD, Ossewaarde JL. Studies on measles virus. II. Physical properties and inactivation studies of measles virus. J Immunol 1960; 85:292-7.
50. Norrby E, Oxman MN. Measles virus. In: Fields BN, Knipe DM, Chanock R, et al. eds. Fields virology. 2nd ed. Vol 1. New York, NY: Raven Press, 1990; 1013-44.